Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FNCH Finch Therapeutics > Detailed Quotes

FNCH Finch Therapeutics

1.750
-0.120-6.42%
Close 09/23 16:00 ET
1.7500.0000.00%
Post Mkt Price 09/23 17:12 ET
High
1.850
Open
1.820
Turnover
118.90K
Low
1.660
Pre Close
1.870
Volume
67.33K
Market Cap
83.45M
P/E(TTM)
Loss
52wk High
17.390
Shares
47.69M
P/E(Static)
Loss
52wk Low
1.660
Float Cap
39.45M
Bid/Ask %
0.00%
Historical High
22.500
Shs Float
22.55M
Volume Ratio
0.85
Historical Low
1.660
Dividend TTM
--
Div Yield TTM
--
P/B
0.52
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.30%
Amplitude
10.16%
Avg Price
1.765
Lot Size
1
Float Cap
39.45M
Bid/Ask %
0.00%
Historical High
22.500
Shs Float
22.55M
Volume Ratio
0.85
Historical Low
1.660
Dividend TTM
--
P/B
0.52
Dividend LFY
--
Turnover Ratio
0.30%
Amplitude
10.16%
Avg Price
1.765
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.
CEO: Dr. Mark Smith, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...